KO

COCA COLA CO
3 filings tracked
consumer staplesbeveragesMEGA (>$200B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

The company is successfully decoupling its brand power from the costs of physical distribution. By exiting bottling operations in India and Nigeria, Coca-Cola is evolving into a leaner entity focused on high-margin concentrate sales.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Operational risks are amplified by the fact that five bottling partners control 44% of unit case volume, creating a dangerous dependency.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every KO filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Coca-Cola Company is undergoing a structural transformation, shifting from a capital-intensive bottling model to a high-margin concentrate and licensing business.…

Latest Available Quarter (Q3 '26 (10-Q))

Core Takeaway

KO is successfully increasing margins through refranchising, but faces a massive IRS liability overhang.

Investor Lens

Investors must weigh the success of the asset-light transition against the risk of a material tax judgment.

Watch Next

The outcome of the IRS transfer-pricing litigation and the completion of the Nigeria divestiture.

Calculated Financial Trajectory (Click to filter signals)

Operating Income / Loss$4359M
the fiscal year ended December 31, '25: $13762Mthe quarter ended April 3, '26: $4359M
Revenue / Net Sales$12472M
the quarter ended April 3, '26: $12472M
Gross Margin62.9%
the quarter ended July 3, '26: 62.9%

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)+0.30Q1 '26 (10-K)+0.30Q2 '26 (10-Q)+0.10Q3 '26 (10-Q)

Signal Timeline

bullishJul 29

Gross margins rose to 62.9% as the company shifted toward a concentrate-heavy model.

margin expansion
70%
bearishJul 29

Ongoing IRS transfer-pricing litigation presents a multi-billion dollar risk.

regulatory action
90%
bullishJul 29

Strategic refranchising of bottling operations in India and Nigeria to reduce capital intensity.

divestiture
60%
neutralJul 29

Aggressive share repurchases totaling $663 million in the first half of 2026.

buyback
50%
bullishApr 30

Operating margins expanded to 35.0% as the company shifts to a concentrate-led model.

margin expansion
80%
bearishApr 30

Ongoing IRS transfer-pricing dispute with a potential $14 billion liability.

regulatory action
90%
bullishApr 30

Strategic exit from African bottling operations to reduce capital intensity.

divestiture
70%
bullishApr 30

Aggressive share repurchases with over 6 million shares retired in Q1.

buyback
60%
bullishFeb 20

Operating income grew 38% as the company shifted to an asset-light model.

margin expansion
80%
bullishFeb 20

Completed refranchising of bottling operations in India, Bangladesh, and the Philippines.

divestiture
70%
bearishFeb 20

Ongoing IRS transfer-pricing dispute with a potential $14 billion liability.

regulatory action
90%
bullishFeb 20

Aggressive share repurchases and a 64-year dividend growth streak.

buyback
60%

Filing History

10-QJul 29, 2026
Expand Sequence

The latest 10-Q presents a company at a crossroads, balancing impressive operational growth against systemic financial risks. While the shift toward a concentrate-heavy model is successfully driving gross margins to 62.9%, the financial statements reveal a heavy reliance on debt and derivatives to maintain the appearance of a fortress balance sheet. The tension between these operational wins and the looming IRS litigation creates a complex risk-reward profile for investors. Ultimately, the investment thesis hinges on whether the gains from refranchising and pricing power can outpace the cost of servicing $37 billion in debt and the potential fallout from tax disputes. The company's ability to sustain its dividend and buyback schedule while navigating these headwinds will be the primary driver of stock performance in the coming quarters.

10-QApr 30, 2026
Expand Sequence

The Q1 2026 filing presents a company at a crossroads between operational excellence and systemic financial risk. While the shift toward a concentrate-led model is delivering immediate margin expansion and strong cash flow, these wins are juxtaposed against a looming regulatory storm. The company's ability to grow revenue by 12.1% while expanding margins suggests a powerful brand moat, yet the balance sheet remains heavily leveraged. Ultimately, the investment case hinges on whether the operational momentum can outpace the potential for a catastrophic tax judgment. The successful closing of the African divestiture by the end of 2026 will serve as a critical validator for the asset-light strategy. Investors are left to weigh the immediate benefits of high-yield returns against the risk of a multi-billion dollar liability.

10-KFeb 20, 2026
Expand Sequence

The 2025 10-K reveals a company in the midst of a high-stakes evolution. While the shift toward a licensing-heavy model has successfully boosted operating income, it has also shifted the risk profile from operational volatility to systemic and regulatory dependency. The company's ability to maintain its dividend and buyback cadence now rests on the successful resolution of its African divestiture and the outcome of its long-standing IRS litigation. Ultimately, the filing presents a tension between a pristine brand-licensing future and the reality of legacy obligations. Investors are left to weigh the impressive growth in operating income against the potential for a multi-billion dollar tax hit and the inherent risks of a highly concentrated bottling network. The transition to an asset-light model is well underway, but the finality of this transformation depends on navigating these contingent liabilities without compromising liquidity.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.